Evidence map›Paper›PMID 41345258›Full record

ArticleScientific reports2025

AMPK affects the development of early-stage NAFLD by activating autophagy and fatty acid oxidation.

Mei-Yu Jin, Hao Yu, Qiong Deng, Zhu Wang, Hui Liang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mei-Yu Jin *Department of urology, People's Hospital of Longhua, Shenzhen, 518109, China.
Hao Yu *State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun, 130062, China.
Qiong Deng *Department of urology, People's Hospital of Longhua, Shenzhen, 518109, China.
Zhu WangDepartment of urology, People's Hospital of Longhua, Shenzhen, 518109, China.
Hui LiangDepartment of urology, People's Hospital of Longhua, Shenzhen, 518109, China. lianghui8689@smu.edu.cn.

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2023A1515220093Natural Science Foundation of Shenzhen Municipality JCYJ20240813114416022
6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) ranks among the most common liver disorders, but the mechanisms underlying its early development are still not well understood. This study aims to compare the effects of varying degrees of lipid accumulation on autophagy and energy metabolism signaling pathways to further elucidate the early pathogenesis of NAFLD. Low-level and classical lipid accumulation models were generated in AML12 and HepG2 cells in vitro using various concentrations of oleic acid and palmitic acid. For in vivo models, Tyloxapol and high-fat diet were utilized to construct both low-level and classical lipid accumulation models. We used Western blot analysis to assess the phosphorylation status of peroxisome proliferator-activated receptor α (PPARα) and AMP-activated protein kinase (AMPK), as well as the expression levels of autophagy-related proteins. We found that low-level lipid accumulation models significantly promoted the expression of the lipid oxidation protein PPARα, and enhanced autophagy activity and AMPK phosphorylation. However, these positive effects were inhibited in classical lipid accumulation models. Our research identified a compensatory mechanism in the early stages of NAFLD. Appropriate lipid accumulation can increase the levels of fatty acid oxidation proteins and autophagy, potentially mediated by the energy metabolism regulator AMPK. This discovery offers additional theoretical insights into the onset and progression of early-stage NAFLD.

Indexed as

AMP-Activated Protein KinasesAutophagyFatty AcidsNon-alcoholic Fatty Liver DiseaseAnimalsDiet, High-FatDisease Models, AnimalHep G2 CellsHumansLipid MetabolismMaleMiceOxidation-ReductionPhosphorylationPPAR alphaSignal TransductionAMP-Activated Protein KinasesFatty AcidsPPAR alphaAMPKAutophagyLipid accumulationLipid oxidationNAFLD

Identifiers

PMID41345258
PMCPMC12795851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.